Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108812148 | 10881214 | 8 | F | 201504 | 20160921 | 20150303 | 20160927 | PER | US-PFIZER INC-2015075108 | PFIZER | 73.00 | YR | F | Y | 90.70000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108812148 | 10881214 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, CYCLIC, ONE A DAY FOR 28 DAYS, THEN OFF FOR 2 WEEKS | Z615B | 21938 | 25 | MG | CAPSULE, HARD | ||||||
| 108812148 | 10881214 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC, 28 DAYS ON AND 14 DAYS OFF | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 108812148 | 10881214 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 1 DF, 1X/DAY (FOR 4 WEEKS) | 21938 | CAPSULE, HARD | QD | ||||||||
| 108812148 | 10881214 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 25 MG, DAILY | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 108812148 | 10881214 | 5 | SS | SUTENT | SUNITINIB MALATE | 1 | 25 MG, CYCLIC (ONE A DAY FOR 28 DAYS AND OFF 14 DAYS) | 378CA | 21938 | 25 | MG | CAPSULE, HARD | |||||||
| 108812148 | 10881214 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, 1X/DAY, 10 MG TABLET ONE IN THE MORNING | 0 | 10 | MG | TABLET | QD | ||||||
| 108812148 | 10881214 | 7 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, DAILY (FOR 90 DAYS) | 0 | 10 | MG | TABLET | |||||||
| 108812148 | 10881214 | 8 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 2.5/500 MG ONE | 0 | ||||||||||
| 108812148 | 10881214 | 9 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 4 MG ONE TABLET AT BEDTIME | 0 | 4 | MG | TABLET | QD | ||||||
| 108812148 | 10881214 | 10 | C | CLONIDINE. | CLONIDINE | 1 | Oral | 0.3 MG ONE TABLET AT NIGHT | 0 | .3 | MG | TABLET | QD | ||||||
| 108812148 | 10881214 | 11 | C | XARELTO | RIVAROXABAN | 1 | Oral | 15 MG, ONE A DAY (DAILY FOR 30 DAYS) | 0 | 15 | MG | TABLET | QD | ||||||
| 108812148 | 10881214 | 12 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 300 MG TWICE A DAY | 0 | 300 | MG | TABLET | BID | ||||||
| 108812148 | 10881214 | 13 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 2 MG, DAILY (FOR 90 DAYS) | 0 | 2 | MG | TABLET | |||||||
| 108812148 | 10881214 | 14 | C | CYCLOBENZAPRINE HYDROCHLORIDE. | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 108812148 | 10881214 | 15 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | UNK | 0 | MODIFIED-RELEASE CAPSULE, SOFT | ||||||||||
| 108812148 | 10881214 | 16 | C | DOXAZOSIN MESYLATE. | DOXAZOSIN MESYLATE | 1 | UNK | 0 | |||||||||||
| 108812148 | 10881214 | 17 | C | ATENOLOL. | ATENOLOL | 1 | UNK | 0 | |||||||||||
| 108812148 | 10881214 | 18 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 3X/DAY | 0 | 150 | MG | CAPSULE | TID | ||||||
| 108812148 | 10881214 | 19 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Oral | UNK UNK, AS NEEDED (HYDROCODONE 10 MG-ACETAMINOPHEN 325 MG) (TWO TIMES DAILY, AS NEEDED) | 0 | TABLET | |||||||||
| 108812148 | 10881214 | 20 | C | CLONIDINE HYDROCHLORIDE. | CLONIDINE HYDROCHLORIDE | 1 | Oral | 0.3 MG, 2X/DAY (FOR 30 DAYS) | 0 | .3 | MG | TABLET | BID | ||||||
| 108812148 | 10881214 | 21 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 108812148 | 10881214 | 22 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | TABLET | BID | ||||||
| 108812148 | 10881214 | 23 | C | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | 1 PUFF, DAILY (INHALATION) | 0 | |||||||||||
| 108812148 | 10881214 | 24 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Nasal | 2 SPRAY, DAILY IN EACH NOSTRIL | 0 | NASAL SPRAY | |||||||||
| 108812148 | 10881214 | 25 | C | FENTANYL. | FENTANYL | 1 | Transdermal | 1 DF, EVERY 72 HOURS | 0 | 1 | DF | TRANSDERMAL PATCH | |||||||
| 108812148 | 10881214 | 26 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 108812148 | 10881214 | 27 | C | CYANOCOBALAMIN. | CYANOCOBALAMIN | 1 | Intramuscular | 1000 UG/ML, WEEKLY | 0 | SOLUTION FOR INJECTION | /wk | ||||||||
| 108812148 | 10881214 | 28 | C | ESCITALOPRAM OXALATE. | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 108812148 | 10881214 | 29 | C | DRAMAMINE | DIMENHYDRINATE | 1 | Oral | 50 MG, AS NEEDED | 0 | 50 | MG | TABLET | |||||||
| 108812148 | 10881214 | 30 | C | AMITRIPTYLINE HCL | AMITRIPTYLINE | 1 | Oral | 10 MG, AS NEEDED (DAILY) | 0 | 10 | MG | TABLET | |||||||
| 108812148 | 10881214 | 31 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, AS NEEDED (DAILY) | 0 | 40 | MG | TABLET | |||||||
| 108812148 | 10881214 | 32 | C | DHEA | PRASTERONE | 1 | Oral | 50 MG, DAILY | 0 | 50 | MG | CAPSULE | |||||||
| 108812148 | 10881214 | 33 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108812148 | 10881214 | 1 | Renal cancer |
| 108812148 | 10881214 | 6 | Hypertension |
| 108812148 | 10881214 | 8 | Diabetes mellitus |
| 108812148 | 10881214 | 9 | Hypertension |
| 108812148 | 10881214 | 10 | Hypertension |
| 108812148 | 10881214 | 11 | Anticoagulant therapy |
| 108812148 | 10881214 | 12 | Dyspepsia |
| 108812148 | 10881214 | 13 | Diabetes mellitus |
| 108812148 | 10881214 | 22 | Blood glucose abnormal |
| 108812148 | 10881214 | 28 | Depression |
| 108812148 | 10881214 | 31 | Oedema |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108812148 | 10881214 | Dizziness | |
| 108812148 | 10881214 | Fatigue | |
| 108812148 | 10881214 | Malaise | |
| 108812148 | 10881214 | Nausea | |
| 108812148 | 10881214 | Oropharyngeal pain | |
| 108812148 | 10881214 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108812148 | 10881214 | 1 | 2013 | 0 |